Completing data — refresh the page later to see the latest
2104-19-0COC(=O)CCCCCCCC(=O)OVVWPSAPZUZXYCM-UHFFFAOYSA-NMethyl hydrogen azelate has been reported in Oryza officinalis with data available.
2104-19-0DTXSID10175253Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 50% (1 of 2) of reports.
Warning
H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
UsesMethyl hydrogen azelate is used as pharmaceutical intermediates.
PreparationAZELAIC ACID MONOMETHYL ESTER was prepared by ozone oxidation using methyl oleate as a raw material and a mixture of acetic acid and n-hexane as a solvent. The synthesis conditions for AZELAIC ACID MONOMETHYL ESTER were: V(methyl oleate):V(mixed solvent) = 1:4, ozonation reaction temperature of 10–13 °C, oxidative pyrolysis temperature of 90–95 °C, and oxidative pyrolysis time of 2.5 h. The crude product was purified by molecular distillation. Under these conditions, the yield of AZELAIC ACID MONOMETHYL ESTER was ≥78%, and the purity was ≥96%.
Loading…